Netilmicin (Sch 20569) ( Fig. 1) , a new semisynthetic aminoglycoside antibiotic, is a derivative of sisomicin, which itself is a derivative of gentamicin CIA. Although gentamicin and sisomicin have similar activity against most organisms (4, 5) , there is evidence that netilmicin is more effective than either gentamicin or sisomicin against certain gentamicin-resistant organisms (6, 9, 11; informational material for SCH 20569, Schering Corp., Bloomfield, N.J., 1975). The purpose ofthis study was to compare the antibacterial activity of netilmicin with that of gentamicin against a variety of gentamicin-susceptible and gentamicin-resistant bacteria.
MATERIALS AND METHODS Bacterial strains. The collection consisted ofAcinetobacter anitratus (7), A. Iwoffi (9) , Bacteroides fragilis (19), Citrobacterfreundii (38) ans, 15; P. cepacia, 10; P. fluorescens, 3; P. maltophilia, 11; P. pseudoalkaligenes, 11; P. putida, 3; P. stutzeri, 7; P. thomasii, 5), Serratia marcescens (5), Staphylococcus albus (41), S. aureus (120), Streptococcus faecalis (38), S. pneumoniae (14) , and betahemolytic streptococci (56). Most of the strains were isolates from patients in St. Thomas's Hospital, but the collection included the following strains from the National Collection of Type Cultures: E. aerogenes (3), K. ozaenae (12), P. rettgeri (7), P. Alkalifaciens (9), P. Stuartii (3), P. Fluorescens (1), P. maltophila (1), P. pseudoalkaligenes (1), P. Stutzeri (3), and S. marcescens (5) . Gentamicin-resistant strains from other sources, mostly in Great Britain, were: E. cloacae (1), E. coli (1), K. aerogenes (1), P. rettgeri (1), P. stuartii (13), P. aeruginosa (14), P. stutzeri (3), S. aureus (6) .
Determination of minimum inhibitory concentrations (MICs). Organisms were grown in nutrient broth (Southern Group Laboratories) at 37°C for 18 h. The medium was supplemented with 10% lysed horse blood for H. influenzae and N. gonorrhoeae and with 10% horse serum for S. pneumoniae. The inoculum of B. fragilis was prepared by scraping cells off-blood agar and suspending them in nutrient broth. Cultures were suitably diluted and 103 to 104 colony-forming units inoculated on serial doubling dilutions of the antibiotics in Diagnostic Sensitivity Test agar (Oxoid CM 261). For B. fragilis, N. gonorrhoeae, and S. pneumoniae, 6 to 10% lysed horse blood was added. For H. influenzae, Columbia agar base (Oxoid CM 331) supplemented with factor V (2%) and factor X (1%) was used. Incubation was at 37°C aerobically (with 10% CO2 for N. gonorrhoeae and S. pneumoniae), except for B. fragilis, which was incubated in an atmosphere of 10% H2, 10% C02, and 80% N2. The MIC was the lowest concentration of antibiotic that resulted in complete suppression of growth after overnight incubation. Linear regression of MICs of gentamicin and netilmicin was performed by the method of least squares after transformation of MICs to log2 of MICs.
Demonstration of enzyme activity. For investigations of aminoglycoside-modifying enzymes, use was made of the cellulose phosphate paper binding system (2) . Suspensions, concentrated 10-to 20-fold, of cells grown at 37°C in Oxoid nutrient broth no. 2 (CM 67) were broken with an ultrasonic disintegrator (MSE Mark II). The resulting preparations were tested for their ability to bind radioactivity from acetyl-coenzyme A or adenosine-5'-triphosphate to aminoglycosides.
For acetylation, each tube contained, in a total Results for the genus Pseudomonas are shown in Fig. 3 . Of the 48 strains ofP. aeruginosa, 58% were susceptible to gentamicin and 56% were susceptible to netilmicin. Most strains resistant to gentamicin were also resistant to netilmicin, but a few that produced aminoglycoside-inactivating enzymes were susceptible to netilmicin. Fewer strains ofPseudomonas spp. (40% of 62 strains) than of P. aeruginosa were susceptible to either agent. Only one strain was resistant to gentamicin but susceptible to netilmicin; this strain, ofP. pseudoalkaligenes, produced AAC(3)I.
Netilmicin was less effective than gentamicin against the genus Acinetobacter in which a number of strains produced AAC(6'). All 16 strains were inhibited by gentamicin at a concentration of 2 ,g/ml, but five strains were resistant to this concentration of netilmicin.
H. influenzae had similar susceptibilities to both agents; MICs of 0.5 to 2 Ag/ml were found for all strains. N. gonorrhoeae was more susceptible to netilmicin (MICs, 2 to 8 jig/ml; geometric mean MIC, 3.3 ,ug/ml) than to gentamicin (MICs, 4 to 16 ,ug/ml; geometric mean MIC, 5.6 ,ug/ml). Neither drug had activity against B. fragilis (MICs, 128 jig/ml).
More than 90% of strains of S. aureus were susceptible to both agents. The ge -sistant strains were often more susceptible to (Fig. 4) . Most of these strains were found to produce two enzymes: AAC(6'), which does not produce resistance to gentamicin (1) , and an enzyme that phosphorylates gentamicin, tobramycin, and kanamycin but not neomycin or amikacin, and so is probably amino- Most strains of S. faecalis were resistant to both agents (MICs, 8 to 32 ,ug/ml), although 4 of the 38 strains had netilmicin MICs of 4 p.g/ml. S. pneumoniae was resistant to both agents (MICs, 32 to 64 jpg/ml). For beta-hemolytic streptococci, MICs ranged from 0.5 to 32 ,ug/ml. At a concentration of 4 ,ug/ml, 70% of strains were inhibited by gentamicin, and 68% were inhibited by netilmicin. Table 1 shows in vitro modifiation of gentamicin, sisomicin, and netilmicin by extracts of representative strains that produce aminoglycoside-inactivating enzymes. Netilmicin was a poorer substrate than gentamicin and sisomicin for AAC(3)I and ANT(2"). Sisomicin was a better substrate than gentamicin for AAC(6'), because this enzyme does not acetylate gentamicin Cl (1). Netilmicin was acetylated by AAC(6') less well than was sisomicin. For AAC(6') from S. aureus netilmicin was a on October 23, 2017 by guest http://aac.asm.org/ Downloaded from poorer substrate than gentamicin. There were two types of APT(2"). For the first type, which was more common, sisomicin was a poorer substrate than gentamicin, and netilmicin was phosphorylated only to a small extent. Gentamicin and sisomicin were equally good substrates of the second type and, although it was a poorer substrate, netilmicin was extensively phosphorylated.
DISCUSSION
Despite the general similarity in activity of gentamicin and netilmicin, there was a number of strains against which netilmicin was more active than gentamicin or sisomicin. These strains were mostly ones found to produce enzymes that inactivated gentamicin but for which netilmicin was a poor substrate, although no evidence of inactivating enzymes was detected in one such strain ofE. coli. Thus, in netilmicin, substitution of an ethyl group on the Cl amino group results in partial protection of the C3 amino and C2" hydroxyl groups from attack by AAC(3)I, ANT(2"), and APT(2"). This protection usually seems to be sufficient to render producers of AAC(3)I and ANT(2") fully susceptible to netilmicin. Protection of netilmicin from attack by ANT(2") has been reported before (6, 11), but for AAC(3)I previous work was contradictory. Soussy and Duval (11) found a strain of E. coli that produced AAC(3)I to be susceptible to netilmicin, whereas Kabins et al. (6) found a strain ofP. aeruginosa to be resistant. Of the organisms that produced this enzyme, we found Enterobacteriaceae always to be susceptible to netilmicin; the strain of P. pseudoalkaligenes and one of the two strains of P. aeruginosa were susceptible and, although the other strain ofP. aeruginosa was resistant (MIC, 16 ,ug/ml), it was more susceptible to netilmicin than to gentamicin (MIC, >128 ,ug/ ml). We find producers of AAC(3)I and ANT(2") generally to be susceptible to amikacin (Phillips et al., manuscript in preparation) in agreement with the suggestion that the L-yamino-a-hydroxybutyryl group substituted on the Cl amino group in amikacin has a similar role to the ethyl group of netilmicin (8) .
The staphylococci that produced APT(2") always produced AAC(6') as well. One cannot separate the individual contributions of these enzymes to resistance, but the strains were generally more susceptible to netilmicin than to gentamicin. They were, however, sufficiently resistant to netilmicin to rule out treatment with this agent. In this finding, we agree with previous work (11).
The C2' amino group of netilmicin is not protected, since AAC(2') acetylated the drug. Strains of P. stuartii and P. rettgeri that produced this enzyme tended to be more resistant to netilmicin than to gentamicin, as was found before (6, 11) .
Although acetylated less than sisomicin, netilmicin was a good substrate of AAC(6') from gram-negative organisms. The strains that produced this enzyme, mostly Acinetobacter spp., were the only ones resistant to netilmicin and sisomicin but susceptible to gentamicin. Netilmicin was a poor substrate of AAC(6') from staphylococci, as is amikacin (3, 10) .
For the Klebsiella-Enterobacter-Serratia group, in which gentamicin resistance was enzyme mediated, correlation between MICs of gentamicin and netilmicin was poor (correlation coefficient, r = 0.57). P. aeruginosa, some gentamicin-resistant strains of which produced inactivating enzymes, also had a low correlation coeffilcient (r = 0.61). In contrast, for groups in which there was a sufflciently wide range of MICs there were good correlation coef- Our studies suggest that, like sisomicin (4, 5), netilmicin does not have appreciably better antibacterial activity than gentamicin against most organisms, but this it is superior against gram-negative organisms whose gentamicin resistance is the result of synthesis of AAC(3)I or ANT(2") and against staphylococci whose gentamicin resistance is due to the production of APT(2") and AAC(6').
